Optimizing Anti-Viral Vaccine Responses: Input from a Non-Specialist
Recently, the research community has had a real-world look at reasons for improving vaccine responses to emerging RNA viruses. Here, a vaccine non-specialist suggests how this might be done. I propose two alternative options and compare the primary alternative option with current practice. The basis...
Main Author: | Philip Serwer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/9/5/255 |
Similar Items
-
Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development
by: Peter Nambala, et al.
Published: (2018-08-01) -
Development of Recombinant Vaccine Using Herpesvirus of Turkey (Hvt) as Vector for Several Viral Diseases in Poultry Industry
by: Risza Hartawan
Published: (2011-03-01) -
Biases in Viral Metagenomics-Based Detection, Cataloguing and Quantification of Bacteriophage Genomes in Human Faeces, a Review
by: Julie Callanan, et al.
Published: (2021-03-01) -
Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines
by: Philip Serwer
Published: (2020-10-01) -
More Evidence of Collusion: a New Prophage-Mediated Viral Defense System Encoded by Mycobacteriophage Sbash
by: Gabrielle M. Gentile, et al.
Published: (2019-03-01)